| Denumire comercială | DCI | Forma farmaceutică | Cod ATC | Cod CIM | Firma / țara deținătoare APP |  |
 |
 |
 |
 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| KARBICOMBI 16 mg/12,5 mg | COMBINATII (CANDESARTANUM CILEXETIL+HYDROCHLOROTHIAZIDUM) | COMPR. | C09DA06 | W57536010 | KRKA, D.D., NOVO MESTO - SLOVENIA | ||||||
| KARBICOMBI 16 mg/12,5 mg | COMBINATII (CANDESARTANUM CILEXETIL+HYDROCHLOROTHIAZIDUM) | COMPR. | C09DA06 | W57536011 | KRKA, D.D., NOVO MESTO - SLOVENIA | ||||||
| KARBICOMBI 16 mg/12,5 mg | COMBINATII (CANDESARTANUM CILEXETIL+HYDROCHLOROTHIAZIDUM) | COMPR. | C09DA06 | W57536012 | KRKA, D.D., NOVO MESTO - SLOVENIA | ||||||
| KARBICOMBI 16 mg/12,5 mg | COMBINATII (CANDESARTANUM CILEXETIL+HYDROCHLOROTHIAZIDUM) | COMPR. | C09DA06 | W57536013 | KRKA, D.D., NOVO MESTO - SLOVENIA | ||||||
| KARBICOMBI 16 mg/12,5 mg | COMBINATII (CANDESARTANUM CILEXETIL+HYDROCHLOROTHIAZIDUM) | COMPR. | C09DA06 | W57536014 | KRKA, D.D., NOVO MESTO - SLOVENIA | ||||||
| KARBICOMBI 16 mg/12,5 mg | COMBINATII (CANDESARTANUM CILEXETIL+HYDROCHLOROTHIAZIDUM) | COMPR. | C09DA06 | W57536015 | KRKA, D.D., NOVO MESTO - SLOVENIA | ||||||
| KARBICOMBI 16 mg/12,5 mg | COMBINATII (CANDESARTANUM CILEXETIL+HYDROCHLOROTHIAZIDUM) | COMPR. | C09DA06 | W57536016 | KRKA, D.D., NOVO MESTO - SLOVENIA | ||||||
| KARBICOMBI 16 mg/12,5 mg | COMBINATII (CANDESARTANUM CILEXETIL+HYDROCHLOROTHIAZIDUM) | COMPR. | C09DA06 | W57536017 | KRKA, D.D., NOVO MESTO - SLOVENIA | ||||||
| KARBICOMBI 16 mg/12,5 mg | COMBINATII (CANDESARTANUM CILEXETIL+HYDROCHLOROTHIAZIDUM) | COMPR. | C09DA06 | W57536018 | KRKA, D.D., NOVO MESTO - SLOVENIA | ||||||
| KARAZEPIN | CARBAMAZEPINUM | COMPR. | N03AF01 | W69234001 | CN UNIFARM S.A. - ROMÂNIA | ||||||
| KAPRUVIA 50 micrograme/ml | DIFELIKEFALINUM | SOL INJ. | V03AX04 | W71262001 | VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA FRANCE - FRANTA | X | |||||
| KAPRUVIA 50 micrograme/ml | DIFELIKEFALINUM | SOL INJ. | V03AX04 | W71262002 | VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA FRANCE - FRANTA | X | |||||
| KANUMA 2 mg/ml | SEBELIPASE ALFA | CONC. PT. SOL. PERF. | A16AB14 | W69025001 | ALEXION EUROPE SAS - FRANTA | X | |||||
| KANJINTI 420 mg | TRASTUZUMABUM | PULB. PT. CONC. PT. SOL. PERF. | L01FD01 | W65030001 | AMGEN EUROPE B.V. - OLANDA | X | |||||
| KANJINTI 150 mg | TRASTUZUMABUM | PULB. PT. CONC. PT. SOL. PERF. | L01FD01 | W65029001 | AMGEN EUROPE B.V. - OLANDA | X | |||||
| KANILAD 50 mg | LACOSAMIDUM | COMPR. FILM. | N03AX18 | W64250001 | MEDOCHEMIE LTD. - CIPRU | ||||||
| KANILAD 50 mg | LACOSAMIDUM | COMPR. FILM. | N03AX18 | W64250002 | MEDOCHEMIE LTD. - CIPRU | ||||||
| KANILAD 50 mg | LACOSAMIDUM | COMPR. FILM. | N03AX18 | W64250003 | MEDOCHEMIE LTD. - CIPRU | ||||||
| KANILAD 50 mg | LACOSAMIDUM | COMPR. FILM. | N03AX18 | W64250004 | MEDOCHEMIE LTD. - CIPRU | ||||||
| KANILAD 50 mg | LACOSAMIDUM | COMPR. FILM. | N03AX18 | W64250005 | MEDOCHEMIE LTD. - CIPRU |
ANMDMR - Nomenclatorul medicamentelor pentru uz uman